A subscription to JoVE is required to view this content. Sign in or start your free trial.
This study presents a protocol for fabricating core-sheath 3D-bio-printed scaffolds for chronic wound healing. Extracellular vesicles are isolated from mesenchymal stem cells, and loaded into the core (alginate) with the sheath made from carboxymethyl cellulose and alginate lyase. This design allows controlled scaffold degradation and efficient EVs release.
This study outlines a detailed protocol for the fabrication of core-sheath 3D-bioprinted scaffolds designed to enhance chronic wound healing. The protocol involves isolating extracellular vesicles (EVs) from mesenchymal stem cells (MSCs), known for their regenerative and immunomodulatory properties. These EVs are then incorporated into a unique scaffold structure. The scaffold features a core composed of alginate loaded with EVs, surrounded by a sheath made of carboxymethyl cellulose and alginate lyase. This innovative design ensures controlled scaffold degradation while promoting efficient and controlled release of EVs at the wound site. The protocol covers key steps, including the preparation and characterization of the EVs, the formulation of bio-inks for 3D bioprinting, and the optimization of printing parameters to achieve the desired core-sheath architecture. By combining structural integrity and bioactivity, the scaffold aims to address the limitations of conventional wound dressings, offering a targeted approach to accelerate tissue regeneration and reduce inflammation in chronic wounds. This method provides a reproducible and scalable strategy for developing advanced biomaterials with potential clinical applications in chronic wound management. The protocol also highlights critical considerations for achieving consistent results, ensuring adaptability for future therapeutic applications.
Chronic wounds, often linked to excessive inflammation, require timely management to prevent serious complications like infections and tissue necrosis, which can lead to amputations. Despite advancements, current treatments remain costly, inconvenient, have side effects, and have limited efficacy, highlighting the need for more curative dressings1,2,3. The development of a new generation of wound dressings specifically designed for chronic wounds is essential to address these challenges. Moreover, the complex nature of wound healing demands dressing materials with a range of ....
The animal research was conducted in full accordance with the ethical standards established by the National Committee of Bioethics and the Animal Ethics Committee of the University of Nizwa. Ethical approval for this study was granted under clearance ID: VCGSR, AREC/01/2023. All animals were housed under standard laboratory conditions, ensuring optimal environmental controls, proper nutrition, and comprehensive care to safeguard their welfare throughout the study. All procedures involving animals adhered strictly to institutional policies, international animal care standards, and the ARRIVE guidelines.
1. Cell culture
The in vivo release of EVs from both the Alg-EVs/CMCh and Alg-EVs/CMCh-AlgLyase scaffolds is depicted in Figure 1B,C. As anticipated, the Alg-EVs/CMCh-AlgLyase scaffold exhibited a more rapid release profile compared to Alg-EVs/CMCh, particularly at the 2 h and 4 h time points. The release of EVs from hydrogels is governed by a combination of physicochemical mechanisms, including diffusion, swelling, erosion, and degradation20. By leveraging .......
A pivotal aspect of the protocol is the core-sheath scaffold design, which is essential for achieving efficient EVs delivery. The design incorporates Alg as the core material and a combination of CMCh with Alglyase as the sheath. This setup facilitates controlled and rapid release of EVs. The core material, Alg, encapsulates the EVs, ensuring their protection and localized delivery. The sheath, composed of CMCh and Alglyase, enables the accelerated degradation of the Alg core, which is critical for the timely release of .......
The authors declare that they have no conflicts of interest.
Special thanks to Said Al-Hashmi and Abdulrahman Almharbi from Happy Production for their excellent work in filming. We also extend our gratitude to the Ministry of Higher Education, Research and Innovation and the University of Nizwa for their financial support and for providing the required resources.
....Name | Company | Catalog Number | Comments |
23 G Purple precision conical Nozzle | Cellink | KT0000002000 | To provide precise extrusion of bioinks with minimal clogging |
Alginate lyase (AlgLyase) | Sigma Aldrich | A1603-100MG | Algyase is an enzyme that degrades alginate. |
Amicon Ultra Centrifugal Filter, 30 kDa MWCO | Merck | UFC9030 | Used to wash PKH-26 labeled-EVs |
BCA assay Kit | Thermo Scientific | 10678484 | To determine the protein/EVs concentration |
Bioprinting System | Regemat | V1 | To fabricate core-sheath scaffold |
Bovine serum albumin (BSA) | sigma-aldrich | 05470-5G | To stop PKH 26 reaction |
Calcium chloride | Sigma Aldrich | C3306-100G | To crosslink and stabilize bioinks in tissue engineering |
Centrifuge | Sigma | 2-16P | Used for EVs isolation |
Centrifuge 5810 R | Eppendorf | 22625101 | Used for cell culture |
Class II Biological Safety Cabinet | Telstar | Bio II Advance | Cell culture |
CryoCube F570 Series - ULT Freezer | Eppendorf | F571240035 | To store EVs |
fluorescent microscope | OLYMPUS | IX73P1F | Used to check the residual PKH-26 in the filtrate |
Gentamicin (50 mg/mL) | Thermofisher | 15750 | Antibiotic for cell culture media |
GlutaMAX-I CTS, (100X), liquid | Thermofisher | A12860 | Cell culture media supplement |
HCl | Sigma Aldrich | 7647-01-0 | Buffer preparation |
HEPES | Carl Roth | Art. No. 6763.3 | Buffer preparation |
High viscous carboxymethyl cellulose (CMCh) | BDH | 27929 4T | CMCh is a water-soluble cellulose derivative. |
Incubator | New Brunswick | NB-170R | Cell culture |
Invivo imaging | PerkinElmer | IVIS Lumina XRMS Series III | To track EVs release, in vivo |
Magnet stirer | SalvisLAB | MC35 | For Bioinks preparation |
miRCURY Exosome Kits for Exosome Isolation | Qiagen | 76743 | Evs isolation |
NaOh | Daejung | 1310-73-2 | Buffer preparation |
phosphate buffered saline(PBS) | Thermo Scientific | J61196.AP | Cell culture |
PKH 26 | MCE | 154214-55-8 | Red fluorescent dye for labeling theEVs |
Sodium alginate (Alg) | Sigma Aldrich | A0682-100G | Natural polysaccharide derived from brown seaweed. |
Sodium chloride (NaCl) | Carl Roth | Art-Nr-P029.1 | Buffer preparation |
StemPro BM Mesenchymal Stem Cells | Thermofisher | A1382901 | Mesenchymal stem cells |
StemPro MSC SFM XenoFree | Thermofisher | A1067501 | Cell culture media |
Trypsin 0.25% | Thermofisher | 25050014 | Cell dissociation |
Vortex-Mixer | Daihan Scientific | VM-10 | Used to mix precipitation buffer with the conditioned media |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved